Synthesis, characterization, and antimicrobial activity of an ampicillin-conjugated magnetic nanoantibiotic for medical applications

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 3801-3814

  Hussein Al Ali, Samer Hasan ^a,b   El Zowalaty, Mohamed Ezzat ^c,d   Hussein, Mohd Zobir ^c   Geilich, Benjamin M ^e   Webster, Thomas J ^e,f  

^a Laboratory of Molecular Biomedicine   (Jordan)

^b ISRA UNIVERSITY   (Jordan)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d JAZAN UNIVERSITY   (Saudi Arabia)

^e Northeastern University   (United States)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

And nanoantibiotics; Antibacterial activity; Chitosan; Coating material; Iron oxide nanoparticles; lactam

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CHITOSAN; MAGNETITE NANOPARTICLE; NANOCOMPOSITE;

BACTERIA; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

AMPICILLIN; ANTI-INFECTIVE AGENTS; BACTERIA; CHITOSAN; MAGNETITE NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; NANOCOMPOSITES;

EID: 84905989485     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S61143     Document Type: Article

References (60)

1. Prodan D, Chanéac C, Tronc E, et al. Adsorption phenomena and magnetic properties of γ-Fe2O3 nanoparticles. J Magnetism Magnetic Mater. 1999;203:63-65.
2. Prodan D, Grecu VV, Grecu MN, Tronc E, Jolivet JP. Electron spin resonance in γ-Fe2O3 nanoparticles dispersed in a polymer matrix. Measurement Sci Technol. 1999;10(9):L41-L43.
3. Predoi D, Kuncser V, Filoti G. Magnetic behaviour of maghemite nanoparticles studied by Mössbauer spectroscopy. Rom Rep Phys. 2004; 56(3):373-378.
4. Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 2012;8(2): 147-166.
5. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008;108(6):2064-2110.
6. Oka H, Tomioka T, Tomita K, Nishino A, Ueda S. Inactivation of enveloped viruses by a silver-thiosulfate complex. Met Based Drugs. 1994;1(5-6):511.
7. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63(1-2): 24-46.
8. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology. 2003;229(3):838-846.
9. Jing XH, Yang L, Duan XJ, et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine. 2008;75(4):432-438.
10. Fortin JP, Wilhelm C, Servais J, Ménager C, Bacri JC, Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc. 2007;129(9): 2628-2635.
11. Mahmoudi M, Shokrgozar MA, Simchi A, et al. Multiphysics flow modeling and in vitro toxicity of iron oxide nanoparticles coated with polyvinyl alcohol. J Phys Chem C. 2009;113:2322-2331.
12. Lübbe AS, Bergemann C, Huhnt W, et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res. 1996; 56(20):4694-4701.
13. Lübbe AS, Bergemann C, Riess H, et al. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 1996;56(20): 4686-4693.
14. Ball AP, Bartlett JG, Craig WA, et al. Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC. J Chemother. 2004; 16(5):419-436.
15. Suárez C, Gudiol F. [Beta-lactam antibiotics]. Enferm Infecc Microbiol Clin. 2009;27(2):116-129. Spanish.
16. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929. Bull World Health Organ. 2001;79(8):780-790.
17. Rolinson GN. Forty years of beta-lactam research. J Antimicrob Chemother. 1998;41(6):589-603.
18. Rolinson GN, Stevens S. Microbiological studies on a new broadspectrum penicilin, "Penbritin". Br Med J. 1961;2(5246):191-196.
19. Stewart GT, Coles HM, Nixon HH, Holt RJ. "Penbritin": An Oral Penicillin with Broad-spectrum Activity. Br Med J. 1961;2(5246): 200-206.
20. Hawkey PM. The origins and molecular basis of antibiotic resistance. BMJ. 1998;317(7159):657-660.
21. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417-433.
22. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century a clinical super-challenge. N Engl J Med. 2009;360(5):439-443.
23. Butler MS, Cooper MA. Antibiotics in the clinical pipeline in 2011. J Antibiot (Tokyo). 2011;64(6):413-425.
24. Wright GD. Antibiotics: a new hope. Chem Biol. 2012;19(1):3-10.
25. Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther. 2011; 9(11):1035-1052.
26. Huh AJ, Kwon YJ. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156(2):128-145.
27. Taubes G. The bacteria fight back. Science. 2008;321(5887): 356-361.
28. Bell IR, Schwartz GE, Boyer NN, Koithan M, Brooks AJ. Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health. Eur J Integr Med. 2013;5(2):126-140.
29. Matthews L, Kanwar RK, Zhou S, Punj V, Kanwar JR. Applications of nanomedicine in antibacterial medical therapeutics and diagnostics. Open Tropical Med J. 2010;3:1-9.
30. Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine. 2012;7:2767-2781.
31. Oloffs A, Grosse-Siestrup C, Bisson S, Rinck M, Rudolph R, Gross U. Biocompatibility of silver-coated polyurethane catheters and silvercoated Dacron material. Biomaterials. 1994;15(10):753-758.
32. Flores M, Colon N, Rivera O, et al. A study of the growth curves of C. xerosis and E. coli bacteria in mediums containing cobalt ferrite nanoparticles. Mat Res Soc Symp Proc. 2004;820:227-234.
33. Williams DN, Ehrman SH, Pulliam Holoman TR. Evaluation of the microbial growth response to inorganic nanoparticles. J Nanobiotechnology. 2006;4:3.
34. Fattal E, Youssef M, Couvreur P, Andremont A. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob Agents Chemother. 1989;33(9):1540-1543.
35. Forestier F, Gerrier P, Chaumard C, Quero AM, Couvreur P, Labarre C. Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages. J Antimicrob Chemother. 1992;30(2):173-179.
36. Balland O, Pinto-Alphandary H, Pecquet S, Andremont A, Couvreur P. The uptake of ampicillin-loaded nanoparticles by murine macrophages infected with Salmonella typhimurium. J Antimicrob Chemother. 1994; 33(3):509-522.
37. Pinto-Alphandary H, Andremont A, Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents. 2000;13(3):155-168.
38. Misra R, Acharya S, Dilnawaz F, Sahoo SK. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles. Nanomedicine (Lond). 2009; 4(5):519-530.
39. Obonyo M, Zhang L, Thamphiwatana S, Pornpattananangkul D, Fu V, Zhang L. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol Pharm. 4, 2012;9(9): 2677-2685.
40. Predoi D. A study on iron oxide nanoparticles coated with dextrin obtained by coprecipitation. Dig J Nanomater Biostruct. 2007;2: 169-173.
41. Inbaraj BS, Tsai T-Y, Chen B-H. Synthesis, characterization and antibacterial activity of superparamagnetic nanoparticles modified with glycol chitosan. Sci Technol Adv Mater. 2012;13(2012):015002.
42. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2008.
43. Usman MS, El Zowalaty ME, Shameli K, Zainuddin N, Salama M, Ibrahim NA. Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomedicine. 2013:8:4467-4479.
44. Glover AL, Bennett JB, Pritchett JS, et al. Magnetic Heating of Iron Oxide Nanoparticles and Magnetic Micelles for Cancer Therapy. IEEE Trans Magn. 2013;49(1):231-235.
45. Silva SML, Braga CRC, Fook MVL, et al. Application of infrared spectroscopy to analysis of chitosan/clay nanocomposite. In: Infrared Spectroscopy Materials Science, Engineering and Technology. Theophile T, editor. Rijeka, Croatia: InTech; 2012.
46. Qu JB, Shao HH, Jing GL, Huang F. PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2013;102:37-44.
47. Trikeriotis M, Ghanotakis DF. Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides. Int J Pharm. 2007; 332(1-2):176-184.
48. Inbaraj BS, Kao TH, Tsai TY, Chiu CP, Kumar R, Chen BH. The synthesis and characterization of poly(γ-glutamic acid)-coated magnetite nanoparticles and their effects on antibacterial activity and cytotoxicity. Nanotechnology. 2011;22(7):075101.
49. Kumar R, Inbaraj BS, Chen BH. Surface modification of superparamagnetic iron nanoparticles with calcium salt of poly (γ-glutamic acid) as coating material. Mater Res Bull. 2010;45:1603-1607.
50. Shan Z, Yang W-S, Zhang X, Huang Q-M, Ye H. Preparation and characterization of carboxyl-group functionalized superparamagnetic nanoparticles and the potential for bio-applications. J Braz Chem Soc. 2007;18:1329-1335.
51. Ambrogi V, Fardella G, Grandolini G, Perioli L, Tiralti MC. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents, II: Uptake of diclofenac for a controlled release formulation. AAPS Pharm Sci Tech. 2002;3(3):E26.
52. bin Hussein MZ, Zainal Z, Yahaya AH, Foo DW. Controlled release of a plant growth regulator, alpha-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite. J Control Release. 2002;82(2-3):417-427.
53. Dong L, Yan L, Hou W-G, Liu S-J. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J Solid State Chem. 2010;183(8):1811-1816.
54. Ho YS, Ofomaja AE. Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiber. J Hazard Mater. 2006;129(1-3):137-142.
55. Sakore S, Chakraborty B. Formulation and evaluation of enalapril maleate sustained release matrix tablets. Int J Pharm. 2013;4:21-26.
56. Goy RC, Britto D, Assis OBG. A review of the antimicrobial activity of chitosan. Polimeros: Cie Tec. 2009;3:1-7. Available at: http://www.sci-elo.br/scielo.php?script=sci_arttext&pid=S0104-14282009000300013. Accessed June 11, 2014.
57. Hajipour MJ, Fromm KM, Ashkarran AA, et al. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012;30(10):499-511.
58. Yacoby I, Benhar I. Antibacterial nanomedicine. Nanomedicine (Lond). 2008;3(3):329-341.
59. Abeylath SC, Turos E, Dickey S, Lim DV. Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg Med Chem. 2008;16(5):2412-2418.
60. Saúde AC, Cherobim MD, Amaral AC, Dias SC, Franco OL. Nanoformulated antibiotics: the next step for pathogenic bacteria control. Curr Med Chem. 2013;20(10):1232-1240.